These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36586013)

  • 1. Tumoral CD105 promotes immunosuppression, metastasis, and angiogenesis in renal cell carcinoma.
    Oladejo M; Nguyen HM; Seah H; Datta A; Wood LM
    Cancer Immunol Immunother; 2023 Jun; 72(6):1633-1646. PubMed ID: 36586013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD105 in the progression and therapy of renal cell carcinoma.
    Oladejo M; Nguyen HM; Wood L
    Cancer Lett; 2023 Aug; 570():216327. PubMed ID: 37499740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neovascularity as a prognostic marker in renal cell carcinoma.
    Bauman TM; Huang W; Lee MH; Abel EJ
    Hum Pathol; 2016 Nov; 57():98-105. PubMed ID: 27436827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CEACAM1 and CD105 in Renal Cell Carcinoma and Its Correlation with Microvessel Density.
    Kang ZP; Wang LX; Liu J; Ouyang H; Xie S; Tan Y
    Crit Rev Eukaryot Gene Expr; 2021; 31(1):1-9. PubMed ID: 33639050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
    Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
    PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Listeria-based immunotherapy directed against CD105 exerts anti-angiogenic and anti-tumor efficacy in renal cell carcinoma.
    Oladejo M; Nguyen HM; Silwal A; Reese B; Paulishak W; Markiewski MM; Wood LM
    Front Immunol; 2022; 13():1038807. PubMed ID: 36439126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
    Raica M; Cimpean AM; Anghel A
    Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infiltrating mast cells promote renal cell carcinoma angiogenesis by modulating PI3K→︀AKT→︀GSK3β→︀AM signaling.
    Chen Y; Li C; Xie H; Fan Y; Yang Z; Ma J; He D; Li L
    Oncogene; 2017 May; 36(20):2879-2888. PubMed ID: 28114284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche.
    Grange C; Tapparo M; Collino F; Vitillo L; Damasco C; Deregibus MC; Tetta C; Bussolati B; Camussi G
    Cancer Res; 2011 Aug; 71(15):5346-56. PubMed ID: 21670082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal carcinoma CD105-/CD44- cells display stem-like properties in vitro and form aggressive tumors in vivo.
    Fiedorowicz M; Khan MI; Strzemecki D; Orzeł J; Wełniak-Kamińska M; Sobiborowicz A; Wieteska M; Rogulski Z; Cheda L; Wargocka-Matuszewska W; Kilian K; Szczylik C; Czarnecka AM
    Sci Rep; 2020 Mar; 10(1):5379. PubMed ID: 32214151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma.
    Saeednejad Zanjani L; Madjd Z; Abolhasani M; Shariftabrizi A; Rasti A; Asgari M
    Cancer Biomark; 2018; 21(4):821-837. PubMed ID: 29286924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogenous expression of endoglin marks advanced renal cancer with distinct tumor microenvironment fitness.
    Momoi Y; Nishida J; Miyakuni K; Kuroda M; Kubota SI; Miyazono K; Ehata S
    Cancer Sci; 2021 Aug; 112(8):3136-3149. PubMed ID: 34091990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD105 is important for angiogenesis: evidence and potential applications.
    Duff SE; Li C; Garland JM; Kumar S
    FASEB J; 2003 Jun; 17(9):984-92. PubMed ID: 12773481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional significance of CD105-positive cells in papillary renal cell carcinoma.
    Matak D; Brodaczewska KK; Szczylik C; Koch I; Myszczyszyn A; Lipiec M; Lewicki S; Szymanski L; Zdanowski R; Czarnecka AM
    BMC Cancer; 2017 Jan; 17(1):21. PubMed ID: 28056882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies.
    Fonsatti E; Sigalotti L; Arslan P; Altomonte M; Maio M
    Curr Cancer Drug Targets; 2003 Dec; 3(6):427-32. PubMed ID: 14683500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers.
    Minhajat R; Mori D; Yamasaki F; Sugita Y; Satoh T; Tokunaga O
    Pathol Int; 2006 Dec; 56(12):717-23. PubMed ID: 17096728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy.
    Kasprzak A; Adamek A
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta1 and CD105 promote the migration of hepatocellular carcinoma-derived endothelium.
    Benetti A; Berenzi A; Gambarotti M; Garrafa E; Gelati M; Dessy E; Portolani N; Piardi T; Giulini SM; Caruso A; Invernici G; Parati EA; Nicosia R; Alessandri G
    Cancer Res; 2008 Oct; 68(20):8626-34. PubMed ID: 18922939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers.
    Minhajat R; Mori D; Yamasaki F; Sugita Y; Satoh T; Tokunaga O
    Virchows Arch; 2006 Feb; 448(2):127-34. PubMed ID: 16177881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma.
    Zhang L; Xu J; Zhou S; Yao F; Zhang R; You W; Dai J; Yu K; Zhang Y; Baheti T; Pu L; Xu J; Qian X; Zhang C; Xia Y; Dai X; Li Q; Wang X
    J Hepatol; 2024 Jan; 80(1):82-98. PubMed ID: 37838036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.